New York, May 17, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Neglected Tropical Diseases Diagnosis Industry" - https://www.reportlinker.com/p06032319/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Neglected Tropical Diseases Diagnosis Market to Reach $10.3 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Neglected Tropical Diseases Diagnosis estimated at US$5.5 Billion in the year 2022, is projected to reach a revised size of US$10.3 Billion by 2030, growing at aCAGR of 8% over the period 2022-2030. Conventional, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$5.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Molecular / Modern segment is readjusted to a revised 9.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 11.7% CAGR
The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.5 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.
Select Competitors (Total 33 Featured)
- Abbott Laboratories
- Beckman Coulter/Danaher
- Bio-Rad Laboratories, Inc.
- Coris Bioconcept SPRL
- DiaSys Diagnostic Systems GmbH
- F. Hoffmann-La Roche Ltd.
- Genome Diagnostics Pvt. Ltd
- InBios International, Inc.
- Life Technology
- Novartis Diagnostics., Ltd.
- Omega Diagnostics Group PLC
- Ortho-Clinical Diagnostics
- Oscar Medicare Pvt Ltd.
- Premier Medical Corporation Ltd.
- Siemens Healthcare
- Thermo Fisher Scientific, Inc.
- Wako Chemicals, Inc.
- ZeptoMetrix
Read the full report: https://www.reportlinker.com/p06032319/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Neglected Tropical Diseases Diagnosis - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Neglected Tropical Diseases
Diagnosis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for
Conventional by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Conventional by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 6: World 16-Year Perspective for Conventional by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Molecular / Modern by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Molecular / Modern by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 9: World 16-Year Perspective for Molecular / Modern by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Centralized by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Centralized by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 12: World 16-Year Perspective for Centralized by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for
Point of Care by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Point of Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 15: World 16-Year Perspective for Point of Care by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Clinical Labs by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Clinical Labs by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 18: World 16-Year Perspective for Clinical Labs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for
Hospitals & Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 21: World 16-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 22: World Recent Past, Current & Future Analysis for Home
Healthcare by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 23: World Historic Review for Home Healthcare by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 24: World 16-Year Perspective for Home Healthcare by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 25: World Neglected Tropical Diseases Diagnosis Market
Analysis of Annual Sales in US$ Million for Years 2014 through
2030
III. MARKET ANALYSIS
UNITED STATES
Neglected Tropical Diseases Diagnosis Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2023 (E)
Table 26: USA Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 27: USA Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 28: USA 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 29: USA Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 30: USA Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 31: USA 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 32: USA Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 33: USA Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR
Table 34: USA 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
CANADA
Table 35: Canada Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 36: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 37: Canada 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 38: Canada Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 39: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 40: Canada 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 41: Canada Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 42: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 43: Canada 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
JAPAN
Neglected Tropical Diseases Diagnosis Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 44: Japan Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 45: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 46: Japan 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 47: Japan Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 48: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 49: Japan 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 50: Japan Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 51: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR
Table 52: Japan 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
CHINA
Neglected Tropical Diseases Diagnosis Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 53: China Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 54: China Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 55: China 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 56: China Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 57: China Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 58: China 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 59: China Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 60: China Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR
Table 61: China 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
EUROPE
Neglected Tropical Diseases Diagnosis Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 62: Europe Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 63: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 64: Europe 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2014, 2023 & 2030
Table 65: Europe Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 66: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 67: Europe 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 68: Europe Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 69: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 70: Europe 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 71: Europe Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 72: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 73: Europe 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
FRANCE
Neglected Tropical Diseases Diagnosis Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 74: France Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 75: France Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 76: France 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 77: France Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 78: France Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 79: France 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 80: France Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 81: France Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 82: France 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
GERMANY
Neglected Tropical Diseases Diagnosis Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2023
(E)
Table 83: Germany Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 84: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 85: Germany 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 86: Germany Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 87: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 88: Germany 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 89: Germany Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 90: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 91: Germany 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
ITALY
Table 92: Italy Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 93: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 94: Italy 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 95: Italy Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 96: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 97: Italy 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 98: Italy Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 99: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR
Table 100: Italy 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
UNITED KINGDOM
Neglected Tropical Diseases Diagnosis Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2023 (E)
Table 101: UK Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 102: UK Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 103: UK 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 104: UK Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 105: UK Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 106: UK 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 107: UK Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 108: UK Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR
Table 109: UK 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
SPAIN
Table 110: Spain Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 111: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 112: Spain 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 113: Spain Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 114: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 115: Spain 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 116: Spain Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 117: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 118: Spain 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
RUSSIA
Table 119: Russia Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 120: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 121: Russia 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2014, 2023 & 2030
Table 122: Russia Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 123: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 124: Russia 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2014, 2023 & 2030
Table 125: Russia Recent Past, Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 126: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 127: Russia 16-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 128: Rest of Europe Recent Past, Current & Future
Analysis for Neglected Tropical Diseases Diagnosis by Method -
Conventional and Molecular / Modern - Independent Analysis of
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032319/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
